Tyrosine phosphatases in vessel wall signaling

Cardiovascular Research

Volumn 65, Issue 3, 2005, Pages 587-598

  Kappert, Kai ^a   Peters, Kevin G ^b   Böhmer, Frank D ^c   Östman, Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Angiogenesis; Antherogenesis; Cardiovascular disease; Cell signaling; Protein tyrosine phosphatase

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; PHOSPHOTYROSINE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; VANADIUM; VANADIUM DERIVATIVE;

ATHEROGENESIS; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; EXPERIMENTAL MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

BLOOD VESSELS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION;

EID: 12344290477     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.08.016     Document Type: Review

References (109)

1. J.N. Andersen, O.H. Mortensen, G.H. Peters, P.G. Drake, L.F. Iversen, and O.H. Olsen Structural and evolutionary relationships among protein tyrosine phosphatase domains Mol. Cell. Biol. 21 2001 7117 7136
2. A.D. Pannifer, A.J. Flint, N.K. Tonks, and D. Barford Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography J. Biol. Chem. 273 1998 10454 10462
3. Y. Wang, W. Guo, L. Liang, and W.J. Esselman Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis J. Biol. Chem. 274 1999 7454 7461
4. A.J. Garton, and N.K. Tonks PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation EMBO J. 13 1994 3763 3771
5. F. Liu, and J. Chernoff Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor Biochem. J. 327 Pt. 1 1997 139 145
6. T. Uchida, T. Matozaki, T. Noguchi, T. Yamao, K. Horita, and T. Suzuki Insulin stimulates the phosphorylation of Tyr538 and the catalytic activity of PTP1C, a protein tyrosine phosphatase with Src homology-2 domains J. Biol. Chem. 269 1994 12220 12228
7. S.R. Lee, K.S. Kwon, S.R. Kim, and S.G. Rhee Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor J. Biol. Chem. 273 1998 15366 15372
8. J.M. Denu, and K.G. Tanner Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation Biochemistry 37 1998 5633 5642
9. T.C. Meng, T. Fukada, and N.K. Tonks Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo Mol. Cell. 9 2002 387 399
10. C. Persson, T. Sjoblom, A. Groen, K. Kappert, U. Engstrom, and U. Hellman Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases Proc. Natl. Acad. Sci. U. S. A. 101 2004 1886 1891
11. K. Meng, A. Rodriguez-Pena, T. Dimitrov, W. Chen, M. Yamin, and M. Noda Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta Proc. Natl. Acad. Sci. U. S. A. 97 2000 2603 2608
12. M. Sorby, J. Sandstrom, and A. Ostman An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1 Oncogene 20 2001 5219 5224
13. R. Schaapveld, B. Wieringa, and W. Hendriks Receptor-like protein tyrosine phosphatases: alike and yet so different Mol. Biol. Rep. 24 1997 247 262
14. G. Jiang, J. den Hertog, J. Su, J. Noel, J. Sap, and T. Hunter Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha Nature 401 1999 606 610
15. G. Jiang, J. den Hertog, and T. Hunter Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface Mol. Cell. Biol. 20 2000 5917 5929
16. J.V. Frangioni, P.H. Beahm, V. Shifrin, C.A. Jost, and B.G. Neel The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence Cell 68 1992 545 560
17. B.G. Neel, H. Gu, and L. Pao The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling Trends. Biochem. Sci. 28 2003 284 293
18. Z. Jia, D. Barford, A.J. Flint, and N.K. Tonks Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B Science 268 1995 1754 1758
19. A. Salmeen, J.N. Andersen, M.P. Myers, N.K. Tonks, and D. Barford Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B Mol. Cell. 6 2000 1401 1412
20. M. Sarmiento, Y.A. Puius, S.W. Vetter, Y.F. Keng, L. Wu, and Y. Zhao Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition Biochemistry 39 2000 8171 8179
21. J. Yang, Z. Cheng, T. Niu, X. Liang, Z.J. Zhao, and G.W. Zhou Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1 J. Biol. Chem. 275 2000 4066 4071
22. M. Kovalenko, K. Denner, J. Sandstrom, C. Persson, S. Gross, and E. Jandt Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1 J. Biol. Chem. 275 2000 16219 16226
23. R.A. Klinghoffer, and A. Kazlauskas Identification of a putative Syp substrate, the PDGF beta receptor J. Biol. Chem. 270 1995 22208 22217
24. C. Persson, C. Savenhed, A. Bourdeau, M.L. Tremblay, B. Markova, and F.D. Bohmer Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase Mol. Cell. Biol. 24 2004 2190 2201
25. H.L. Palka, M. Park, and N.K. Tonks Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1 J. Biol. Chem. 278 2003 5728 5735
26. F.G. Haj, P.J. Verveer, A. Squire, B.G. Neel, and P.I. Bastiaens Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum Science 295 2002 1708 1711
27. C. Bianchi, F.W. Sellke, R.L. Del Vecchio, N.K. Tonks, and B.G. Neel Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo Exp. Cell Res. 248 1999 329 338
28. L.G. Borges, R.A. Seifert, F.J. Grant, C.E. Hart, C.M. Disteche, and S. Edelhoff Cloning and characterization of rat density enhanced phosphatase 1, a protein tyrosine phosphatase expressed by vascular cells Circ. Res. 79 1996 570 580
29. F. Gaits, R.Y. Li, A. Ragab, J.M. Ragab Thomas, and H. Chap Increase in receptor-like protein tyrosine phosphatase activity and expression level on density-dependent growth arrest of endothelial cells Biochem. J. 311 Pt. 1 1995 97 103
30. T. Takahashi, K. Takahashi, P.L. St John, P.A. Fleming, T. Tomemori, and T. Watanabe A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development Mol. Cell. Biol. 23 2003 1817 1831
31. M. Grazia Lampugnani, A. Zanetti, M. Corada, T. Takahashi, G. Balconi, and F. Breviario Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148 J. Cell Biol. 161 2003 793 804
32. R. Nawroth, G. Poell, A. Ranft, S. Kloep, U. Samulowitz, and G. Fachinger VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts EMBO J. 21 2002 4885 4895
33. G. Fachinger, U. Deutsch, and W. Risau Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2 Oncogene 18 1999 5948 5953
34. L.J. Holsinger, K. Ward, B. Duffield, J. Zachwieja, and B. Jallal The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn) Oncogene 21 2002 7067 7076
35. G.C. Zondag, A.B. Reynolds, and W.H. Moolenaar Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates the catenin p120(ctn) J. Biol. Chem. 275 2000 11264 11269
36. S.M. Brady-Kalnay, D.L. Rimm, and N.K. Tonks Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo J. Cell Biol. 130 1995 977 986
37. D.Q. Guo, L.W. Wu, J.D. Dunbar, O.N. Ozes, L.D. Mayo, and K.M. Kessler Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation J. Biol. Chem. 275 2000 11216 11221
38. M. Sugano, K. Tsuchida, and N. Makino Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia Circulation 109 2004 797 802
39. J. Kroll, and J. Waltenberger The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells J. Biol. Chem. 272 1997 32521 32527
40. S. Soeda, T. Shimada, S. Koyanagi, T. Yokomatsu, T. Murano, and S. Shibuya An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase FEBS Lett. 524 2002 54 58
41. L. Huang, S. Sankar, C. Lin, C.D. Kontos, A.D. Schroff, and E.H. Cha HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity J. Biol. Chem. 274 1999 38183 38188
42. L. Huang, C.W. Turck, P. Rao, and K.G. Peters GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase Oncogene 11 1995 2097 2103
43. N. Jones, S.H. Chen, C. Sturk, Z. Master, J. Tran, and R.S. Kerbel A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function Mol. Cell. Biol. 23 2003 2658 2668
44. C.D. Kontos, T.P. Stauffer, W.P. Yang, J.D. York, L. Huang, and M.A. Blanar Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt Mol. Cell. Biol. 18 1998 4131 4140
45. S.M. Brady-Kalnay, A.J. Flint, and N.K. Tonks Homophilic binding of PTP mu, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation J. Cell Biol. 122 1993 961 972
46. E.A. Koop, S.M. Lopes, E. Feiken, H.A. Bluyssen, M. van der Valk, and E.E. Voest Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice Int. J. Dev. Biol. 47 2003 345 354
47. L.J. Thompson, J. Jiang, N. Madamanchi, M.S. Runge, and C. Patterson PTP-epsilon, a tyrosine phosphatase expressed in endothelium, negatively regulates endothelial cell proliferation Am. J. Physiol. Heart. Circ. Physiol. 281 2001 H396 H403
48. A. Peretz, H. Gil-Henn, A. Sobko, V. Shinder, B. Attali, and A. Elson Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon EMBO J. 19 2000 4036 4045
49. M. Maas, R. Wang, C. Paddock, S. Kotamraju, B. Kalyanaraman, and P.J. Newman Reactive oxygen species induce reversible PECAM-1 tyrosine phosphorylation and SHP-2 binding Am. J. Physiol. Heart. Circ. Physiol. 285 2003 H2336 H2344
50. S. Banai, Y. Wolf, G. Golomb, A. Pearle, J. Waltenberger, and I. Fishbein PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine Circulation 97 1998 1960 1969
51. O. Leppanen, N. Janjic, M.A. Carlsson, K. Pietras, M. Levin, and C. Vargeese Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model Arterioscler. Thromb. Vasc. Biol. 20 2000 E89 E95
52. J. Saltis, A. Agrotis, and A. Bobik Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent J. Hypertens. 11 1993 629 637
53. B. Markova, P. Herrlich, L. Ronnstrand, and F.D. Bohmer Identification of protein tyrosine phosphatases associating with the PDGF receptor Biochemistry 42 2003 2691 2699
54. S. Ekman, A. Kallin, U. Engstrom, C.H. Heldin, and L. Ronnstrand SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF beta-receptor Oncogene 21 2002 1870 1875
55. E. Jandt, K. Denner, M. Kovalenko, A. Ostman, and F.D. Bohmer The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion Oncogene 22 2003 4175 4185
56. F.G. Haj, B. Markova, L.D. Klaman, F.D. Bohmer, and B.G. Neel Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B J. Biol. Chem. 278 2003 739 744
57. P. Chiarugi, P. Cirri, G. Raugei, G. Camici, F. Dolfi, and A. Berti PDGF receptor as a specific in vivo target for low M(r) phosphotyrosine protein phosphatase FEBS Lett. 372 1995 49 53
58. P. Chiarugi, P. Cirri, M.L. Taddei, E. Giannoni, T. Fiaschi, and F. Buricchi Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation J. Biol. Chem. 277 2002 37331 37338
59. N. Seki, N. Hashimoto, Y. Suzuki, S. Mori, K. Amano, and Y. Saito Role of SRC homology 2-containing tyrosine phosphatase 2 on proliferation of rat smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 22 2002 1081 1085
60. M.B. Wright, R.A. Seifert, and D.F. Bowen-Pope Protein-tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury Arterioscler. Thromb. Vasc. Biol. 20 2000 1189 1198
61. J. Suzuki, M. Iwai, H. Nakagami, L. Wu, R. Chen, and T. Sugaya Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation Circulation 106 2002 847 853
62. H. Matsubara Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases Circ. Res. 83 1998 1182 1191
63. Y. Shibasaki, H. Matsubara, Y. Nozawa, Y. Mori, H. Masaki, and A. Kosaki Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase Hypertension 38 2001 367 372
64. Y.H. Feng, Y. Sun, and J.G. Douglas Gbeta gamma-independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1 Proc. Natl. Acad. Sci. U. S. A. 99 2002 12049 12054
65. T. Doan, P. Farmer, T. Cooney, and M.S. Ali Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells Cell. Signal. 16 2004 301 311
66. T. Cui, H. Nakagami, M. Iwai, Y. Takeda, T. Shiuchi, and L. Daviet Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell Cardiovasc. Res. 49 2001 863 871
67. C. Brown, Y. Lin, and A. Hassid Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility Am. J. Physiol. Heart. Circ. Physiol. 281 2001 H1598 H1605
68. N. Sreejayan, Y. Lin, and A. Hassid NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B mediated mechanism Arterioscler. Thromb. Vasc. Biol. 22 2002 1086 1092
69. A. Hassid, S. Huang, and J. Yao Role of PTP 1B in aortic smooth muscle cell motility and tyrosine phosphorylation of focal adhesion proteins Am. J. Physiol. 277 1999 H192 H198
70. A. Hassid, J. Yao, and S. Huang NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation Am. J. Physiol. 277 1999 H1014 H1026
71. Y. Lin, A.C. Ceacareanu, and A. Hassid Nitric oxide induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk Am. J. Physiol. Heart. Circ. Physiol. 285 2003 H710 H721
72. M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, and A.L. Loy Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 283 1999 1544 1548
73. L.D. Klaman, O. Boss, O.D. Peroni, J.K. Kim, J.L. Martino, and J.M. Zabolotny Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice Mol. Cell. Biol. 20 2000 5479 5489
74. T.O. Johnson, J. Ermolieff, and M.R. Jirousek Protein tyrosine phosphatase 1B inhibitors for diabetes Nat. Rev., Drug Discov. 1 2002 696 709
75. R.H. van Huijsduijnen, A. Bombrun, and D. Swinnen Selecting protein tyrosine phosphatases as drug targets Drug Discov. Today 7 2002 1013 1019
76. S.D. Taylor Inhibitors of protein tyrosine phosphatase 1B (PTP1B) Curr. Top. Med. Chem. 3 2003 759 782
77. E.A. Harley, and N. Levens Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances Curr. Opin. Investig. Drugs 4 2003 1179 1189
78. H.G. Cheon, S.M. Kim, S.D. Yang, J.D. Ha, and J.K. Choi Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent Eur. J. Pharmacol. 485 2004 333 339
79. C. Dufresne, P. Roy, Z. Wang, E. Asante-Appiah, W. Cromlish, and Y. Boie The development of potent non-peptidic PTP-1B inhibitors Bioorg. Med. Chem. Lett. 14 2004 1039 1042
80. K. Lee, and T.R. Burke Jr. CD45 protein-tyrosine phosphatase inhibitor development Curr. Top. Med. Chem. 3 2003 797 807
81. I.K. Lund, H.S. Andersen, L.F. Iversen, O.H. Olsen, K.B. Moller, and A.K. Pedersen Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase {beta} J. Biol. Chem. 279 2004 24226 24235
82. A.N. Carr, M.G. Davis, E. Eby-Wilkens, B.W. Howard, B.A. Towne, and T.E. Dufresne Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease Am. J. Physiol. Heart. Circ. Physiol. 287 2004 H268 H276
83. V. Natarajan, W.M. Scribner, and S. Vepa Phosphatase inhibitors potentiate 4-hydroxynonenal-induced phospholipase D activation in vascular endothelial cells Am. J. Respir. Cell. Mol. Biol. 17 1997 251 259
84. Y. Yuan, F.Y. Meng, Q. Huang, J. Hawker, and H.M. Wu Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function Am. J. Physiol. 275 1998 H84 H93
85. J.G. Garcia, K.L. Schaphorst, A.D. Verin, S. Vepa, C.E. Patterson, and V. Natarajan Diperoxovanadate alters endothelial cell focal contacts and barrier function: role of tyrosine phosphorylation J. Appl. Physiol. 89 2000 2333 2343
86. E. Suzuki, D. Nagata, M. Yoshizumi, M. Kakoki, A. Goto, and M. Omata Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor. Possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase J. Biol. Chem. 275 2000 3637 3644
87. H. Shimizu, H. Takayama, J.D. Lee, K. Satake, T. Taniguchi, and H. Yamamura Effects of vanadate on prostacyclin and endothelin-1 production and protein-tyrosine phosphorylation in human endothelial cells Thromb. Haemost. 72 1994 973 978
88. A. Helgadottir, H. Halldorsson, K. Magnusdottir, M. Kjeld, and G. Thorgeirsson A role for tyrosine phosphorylation in generation of inositol phosphates and prostacyclin production in endothelial cells Arterioscler. Thromb. Vasc. Biol. 17 1997 287 294
89. G.R. Hellermann, B.R. Flam, D.C. Eichler, and L.P. Solomonson Stimulation of receptor-mediated nitric oxide production by vanadate Arterioscler. Thromb. Vasc. Biol. 20 2000 2045 2050
90. R. Nakaike, H. Shimokawa, M.K. Owada, O. Tokunaga, H. Yasutake, and T. Kishimoto Vanadate causes synthesis of endothelium-derived NO via pertussis toxin-sensitive G protein in pigs Am. J. Physiol. 271 1996 H296 H302
91. I. Fleming, B. Fisslthaler, and R. Busse Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases Circ. Res. 76 1995 522 529
92. 2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress Circ. Res. 82 1998 686 695
93. C. Yang, J. Chang, M. Gorospe, and A. Passaniti Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation Cell Growth Differ. 7 1996 161 171
94. P.A. Maher Stimulation of endothelial cell proliferation by vanadate is specific for microvascular endothelial cells J. Cell. Physiol. 151 1992 549 554
95. R. Montesano, M.S. Pepper, D. Belin, J.D. Vassalli, and L. Orci Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases J. Cell. Physiol. 134 1988 460 466
96. T. Asahara, C. Bauters, C. Pastore, M. Kearney, S. Rossow, and S. Bunting Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery Circulation 91 1995 2793 2801
97. O. Leppanen, J. Rutanen, M.O. Hiltunen, T.T. Rissanen, M.P. Turunen, and T. Sjoblom Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits Circulation 109 2004 1140 1146
98. D.W. Losordo, J.M. Isner, and L.J. Diaz-Sandoval Endothelial recovery: the next target in restenosis prevention Circulation 107 2003 2635 2637
99. M. Yamashita, P. Dimayuga, S. Kaul, P.K. Shah, J. Regnstrom, and J. Nilsson Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide Lab. Invest. 79 1999 935 944
100. T.V. Murphy, B.E. Spurrell, and M.A. Hill Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension Am. J. Physiol. Heart. Circ. Physiol. 281 2001 H1047 H1056
101. L.P. Adam, M.T. Franklin, G.J. Raff, and D.R. Hathaway Activation of mitogen-activated protein kinase in porcine carotid arteries Circ. Res. 76 1995 183 190
102. M. Osawa, M. Masuda, K. Kusano, and K. Fujiwara Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule? J. Cell Biol. 158 2002 773 785
103. N. Lerner-Marmarosh, M. Yoshizumi, W. Che, J. Surapisitchat, H. Kawakatsu, and M. Akaike Inhibition of tumor necrosis factor-[alpha]-induced SHP-2 phosphatase activity by shear stress: a mechanism to reduce endothelial inflammation Arterioscler. Thromb. Vasc. Biol. 23 2003 1775 1781
104. R.F. Paulson, S. Vesely, K.A. Siminovitch, and A. Bernstein Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1 Nat. Genet. 13 1996 309 315
105. K. Nakayama, K. Takahashi, L.D. Shultz, K. Miyakawa, and K. Tomita Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase Int. J. Exp. Pathol. 78 1997 245 257
106. M.H. Bassett, C. Patterson, and M.R. Runge Expression and regulation of protein tyrosine phosphatase (PTP) LAR in vascular smooth muscle cells (VSMC): evidence for a role in proliferation Circulation suppl.g8 1998 327
107. K. Norris, F. Norris, D.H. Kono, H. Vestergaard, O. Pedersen, and A.N. Theofilopoulos Expression of protein-tyrosine phosphatases in the major insulin target tissues FEBS Lett. 415 1997 243 248
108. H. Shimizu, M. Shiota, N. Yamada, K. Miyazaki, N. Ishida, and S. Kim Low M(r) protein tyrosine phosphatase inhibits growth and migration of vascular smooth muscle cells induced by platelet-derived growth factor Biochem. Biophys. Res. Commun. 289 2001 602 607
109. M.B. Marrero, V.J. Venema, H. Ju, D.C. Eaton, and R.C. Venema Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2 Am. J. Physiol. 275 1998 C1216 C1223